Stacey R. Lewis

Antistaphylococcal Activity of TD-1792, a Multivalent Glycopeptide-Cephalosporin Antibiotic

Johanne Blais, Stacey R. Lewis, Kevin M. Krause et al. · Antimicrobial Agents and Chemotherapy · 2011 · 45 citations

Multivalent Glycopeptide-cephalosporin Antibiotic, Microbial Pathogens, Glycobiology +21

Specificity of Induction of the <i>vanA</i> and <i>vanB</i> Operons in Vancomycin-Resistant Enterococci by Telavancin

Craig Hill, Kevin M. Krause, Stacey R. Lewis et al. · Antimicrobial Agents and Chemotherapy · 2010 · 42 citations · Full text

Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia

Sharath S. Hegde, Robert Skinner, Stacey R. Lewis et al. · Journal of Antimicrobial Chemotherapy · 2010 · 31 citations

Evaluation of Staphylococcus aureus eradication therapy in orthopaedic surgery

Shao‐Ting Jerry Tsang, M. McHugh, Daniel Guerendiain et al. · Journal of Medical Microbiology · 2018 · 26 citations

In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia

Kevin M. Krause, Johanne Blais, Stacey R. Lewis et al. · Diagnostic Microbiology and Infectious Disease · 2012 · 13 citations

Health Sciences, Antibiotics, Klebsiella Pneumoniae +9